MONDAY, Nov. 13 (HealthDay News) -- A novel medication “system” for heart patients, which first administers an anti-clotting drug and then adds an antidote to neutralize the effect, has passed an initial safety test in humans, researchers announced Monday. >>> Discuss This Story
